Rocket Pharmaceuticals, Inc.

RCKT · NASDAQ
Analyze with AI
12/31/2024
12/31/2023
12/31/2022
12/31/2021
Assets
Cash & Equivalents$163,635$55,904$140,517$232,694
Short-Term Investments$208,701$317,271$215,877$156,046
Receivables$0$0$0$0
Inventory$0$0$0$0
Other Curr. Assets$5,847$5,047$7,666$3,319
Total Curr. Assets$378,183$378,222$364,060$392,059
Property Plant & Equip (Net)$83,322$87,590$77,645$72,348
Goodwill$39,154$39,154$39,154$30,815
Intangibles$25,150$25,150$25,724$0
Long-Term Investments$0$34,320$43,276$0
Tax Assets$0$0$0$0
Other NC Assets$1,891$1,905$1,948$1,798
Total NC Assets$149,517$188,119$187,747$104,961
Other Assets$0$0$0$0
Total Assets$527,700$566,341$551,807$497,020
Liabilities
Payables$0$0$0$0
Short-Term Debt$2,857$2,716$2,509$2,552
Tax Payable$0$0$0$0
Deferred Revenue$0$0$0$0
Other Curr. Liab.$37,827$45,789$36,660$19,615
Total Curr. Liab.$40,684$48,505$39,169$22,167
LT Debt$22,641$22,326$20,357$20,049
Deferred Rev, NC$0$0$0$0
Deferred Tax Liab, NC$0$0$0$0
Other NC Liab.$1,141$2,936$2,595$80
Total NC Liab.$23,782$25,262$22,952$20,129
Other Liabilities$0$0$0$0
Cap. Leases$25,498$25,042$22,866$22,601
Total Liabilities$64,466$73,767$62,121$42,296
Equity
Pref Stock$0$0$0$0
Common Stock$1,065$903$791$645
Retained Earnings-$1,218,116-$959,370-$713,775-$491,912
AOCI$66$319-$357-$161
Other Equity$1,680,219$1,450,722$1,203,027$946,152
Total Equity$463,234$492,574$489,686$454,724
Supplemental Information
Minority Interest$0$0$0$0
Total Liab. & Tot. Equity$527,700$566,341$551,807$497,020
Net Debt-$138,137-$30,862-$117,651-$210,093
Rocket Pharmaceuticals, Inc. (RCKT) Financial Statements & Key Stats | AlphaPilot